Somatic Testing

Somatic testing is essential for pancreatic cancer patients, employing next-generation sequencing and molecular profiling to analyze tumor DNA. This precision medicine approach identifies specific mutations, enabling targeted treatments that improve patient outcomes, predict responses, and provide access to clinical trials. By personalizing treatment plans based on genetic insights, somatic testing enhances the effectiveness of care and offers new hope in the fight against pancreatic cancer.